Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available
Secretory carcinoma (SC) is a recently described entity occurring in the salivary glands. Before its description, SC was frequently classified as acinic cell carcinoma (ACC) or adenocarcinoma, not otherwise specified. Its particular histopathological and immunohistochemical characteristics are remin...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Pathology |
Online Access: | http://dx.doi.org/10.1155/2019/5103496 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841524419928784896 |
---|---|
author | Nelson Montalvo David Galarza Ligia Redrobán |
author_facet | Nelson Montalvo David Galarza Ligia Redrobán |
author_sort | Nelson Montalvo |
collection | DOAJ |
description | Secretory carcinoma (SC) is a recently described entity occurring in the salivary glands. Before its description, SC was frequently classified as acinic cell carcinoma (ACC) or adenocarcinoma, not otherwise specified. Its particular histopathological and immunohistochemical characteristics are reminiscent of breast secretory carcinoma. Moreover, it displays a characteristic t(12;15) (p13;q25) translocation that results in the ETV6-NTRK3 gene fusion. This translocation has not been reported in any other salivary gland carcinoma. Identification of the t(12;15) (p13;q25) translocation is the gold standard for diagnosis, although some cases that do not present this specific translocation have already been reported. In such cases, diagnosis is challenging. In addition, some diagnostic pathology laboratories lack the resources to perform the molecular analysis to diagnose SC. In this scenario, morphology and immunohistochemistry are fundamental. Therefore, we report a case emphasizing the typical morphology of SC and its immunochemical profile to establish a final diagnosis without molecular biology tests. This case aims to demonstrate the importance of recognizing the typical presentation of a rare tumor so that clinicians will be informed or reminded of it and consider this entity among the differential diagnoses, when necessary. Moreover, in low-resource settings where molecular analysis is not available, being familiar enough with the histology of this tumor and using the immunoprofile as a key tool for differential diagnosis would be of great importance in establishing the correct diagnosis. The differential diagnosis includes, above all, acinic cell carcinoma and other salivary neoplasms such as intraductal carcinoma, low-grade mucoepidermoid carcinoma, and adenocarcinoma, not otherwise specified, which is actually a rule-out diagnosis. |
format | Article |
id | doaj-art-ceea7148d36b4aa396b5c7e45484d7a6 |
institution | Kabale University |
issn | 2090-6781 2090-679X |
language | English |
publishDate | 2019-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Pathology |
spelling | doaj-art-ceea7148d36b4aa396b5c7e45484d7a62025-02-03T05:53:20ZengWileyCase Reports in Pathology2090-67812090-679X2019-01-01201910.1155/2019/51034965103496Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not AvailableNelson Montalvo0David Galarza1Ligia Redrobán2Facultad de Ciencias Médicas de la Salud y la Vida, Escuela de Medicina, Área de Ciencias Básicas, Cátedra de Patología, Universidad Internacional del Ecuador. Servicio de Patología, Hospital Metropolitano. Av. Mariana de Jesús s/n y Nicolás Arteta. Quito, EcuadorFacultad de Ciencias Médicas de la Salud y la Vida, Escuela de Medicina, Docencia y Departamento de Investigación, Universidad Internacional del Ecuador, EcuadorServicio de Patología, Hospital Metropolitano, EcuadorSecretory carcinoma (SC) is a recently described entity occurring in the salivary glands. Before its description, SC was frequently classified as acinic cell carcinoma (ACC) or adenocarcinoma, not otherwise specified. Its particular histopathological and immunohistochemical characteristics are reminiscent of breast secretory carcinoma. Moreover, it displays a characteristic t(12;15) (p13;q25) translocation that results in the ETV6-NTRK3 gene fusion. This translocation has not been reported in any other salivary gland carcinoma. Identification of the t(12;15) (p13;q25) translocation is the gold standard for diagnosis, although some cases that do not present this specific translocation have already been reported. In such cases, diagnosis is challenging. In addition, some diagnostic pathology laboratories lack the resources to perform the molecular analysis to diagnose SC. In this scenario, morphology and immunohistochemistry are fundamental. Therefore, we report a case emphasizing the typical morphology of SC and its immunochemical profile to establish a final diagnosis without molecular biology tests. This case aims to demonstrate the importance of recognizing the typical presentation of a rare tumor so that clinicians will be informed or reminded of it and consider this entity among the differential diagnoses, when necessary. Moreover, in low-resource settings where molecular analysis is not available, being familiar enough with the histology of this tumor and using the immunoprofile as a key tool for differential diagnosis would be of great importance in establishing the correct diagnosis. The differential diagnosis includes, above all, acinic cell carcinoma and other salivary neoplasms such as intraductal carcinoma, low-grade mucoepidermoid carcinoma, and adenocarcinoma, not otherwise specified, which is actually a rule-out diagnosis.http://dx.doi.org/10.1155/2019/5103496 |
spellingShingle | Nelson Montalvo David Galarza Ligia Redrobán Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available Case Reports in Pathology |
title | Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available |
title_full | Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available |
title_fullStr | Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available |
title_full_unstemmed | Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available |
title_short | Secretory Carcinoma of the Parotid: Making the Correct Diagnosis of a Rare Salivary Gland Carcinoma When Molecular Biology Testing Is Not Available |
title_sort | secretory carcinoma of the parotid making the correct diagnosis of a rare salivary gland carcinoma when molecular biology testing is not available |
url | http://dx.doi.org/10.1155/2019/5103496 |
work_keys_str_mv | AT nelsonmontalvo secretorycarcinomaoftheparotidmakingthecorrectdiagnosisofararesalivaryglandcarcinomawhenmolecularbiologytestingisnotavailable AT davidgalarza secretorycarcinomaoftheparotidmakingthecorrectdiagnosisofararesalivaryglandcarcinomawhenmolecularbiologytestingisnotavailable AT ligiaredroban secretorycarcinomaoftheparotidmakingthecorrectdiagnosisofararesalivaryglandcarcinomawhenmolecularbiologytestingisnotavailable |